UC-961
Showing 1 - 25 of 978
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (Cirmtuzumab (2-16
Recruiting
- B-cell Chronic Lymphocytic Leukemia
- +3 more
- Cirmtuzumab (2-16 kg/mg) plus Ibrutinib
- +5 more
-
Duarte, California
- +12 more
Jun 16, 2022
Breast Tumors Trial in La Jolla (Cirmtuzumab + Paclitaxel)
Active, not recruiting
- Breast Neoplasms
- Cirmtuzumab + Paclitaxel
-
La Jolla, CaliforniaUniversity of California, San Diego
May 16, 2022
Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)
Not yet recruiting
- Lymphoma, Mantle-Cell
- +7 more
- Zilovertamab
- +2 more
- (no location specified)
Jun 21, 2022
Chronic Lymphocytic Leukemia Trial in La Jolla (cirmtuzumab)
Completed
- Chronic Lymphocytic Leukemia
-
La Jolla, CaliforniaUCSD Moores Cancer Center
Jul 29, 2020
Chronic Lymphocytic Leukemia Trial in La Jolla (cirmtuzumab)
Completed
- Chronic Lymphocytic Leukemia
-
La Jolla, CaliforniaUC San Diego Moores Cancer Center
Mar 18, 2019
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +11 more
- Zilovertamab vedotin
-
Duarte, California
- +13 more
Jan 12, 2023
Colitis, Ulcerative, IBD Trial in Worldwide (Placebo IV, Placebo SC, Ustekinumab IV)
Completed
- Colitis, Ulcerative
- Inflammatory Bowel Diseases
- Placebo IV
- +3 more
-
Birmingham, Alabama
- +253 more
Jan 3, 2023
Sickle Cell Disease Trial in Worldwide (Etavopivat Tablets, Placebo Tablets)
Recruiting
- Sickle Cell Disease
- Etavopivat Tablets Low dose
- +3 more
-
Birmingham, Alabama
- +77 more
Oct 11, 2022
Ozanimod Exposure During Pregnancy in Ulcerative Colitis and
Not yet recruiting
- Ulcerative Colitis
- Ozanimod
- +2 more
-
Eden Prairie, MinnesotaOptumInsight Life Sciences Inc
Nov 9, 2023
Acute-On-Chronic Liver Failure Trial in Beijing (standard medical treatment, hUC-MSC at week0, Placebo at week0)
Not yet recruiting
- Acute-On-Chronic Liver Failure
- standard medical treatment
- +10 more
-
Beijing, Beijing, Chinathe Fifth Medical Center, Chinese PLA General Hospital
Aug 15, 2023
Weaning Failure Trial in Leuven (Procedure: Usual Care (UC), Procedure: UC + HI-IMT, Procedure: UC + LI-IMT (sham IMT))
Not yet recruiting
- Weaning Failure
- Procedure: Usual Care (UC)
- +2 more
-
Leuven, BelgiumUniversity Hospital Leuven
Mar 8, 2022
UC-MSC Transplantation in Patients With Retinitis Pigmentosa
Enrolling by invitation
- Retinitis Pigmentosa
- Conditioned Medium (CM)
- Umbilical Cord Mesenchymal Stem Cell (UC-MSC)
-
Jakarta, DKI Jakarta, Indonesia
- +1 more
Mar 14, 2023
IBD Trial (Mesalamine, Nifuroxazide)
Not yet recruiting
- Inflammatory Bowel Diseases
- (no location specified)
Aug 4, 2023
Mesenchymal Stem Cell, COVID-19 Pneumonia Trial in Shanghai (umbilical cord mesenchymal stem cells, paxlovid)
Recruiting
- Mesenchymal Stem Cell
- COVID-19 Pneumonia
- umbilical cord mesenchymal stem cells
- paxlovid
-
Shanghai, Shanghai, ChinaShanghai East Hospital, Shanghai Tongji University
Jan 10, 2023
Ulcerative Colitis Trial (2'-Fucosyllactose, Placebo)
Not yet recruiting
- Ulcerative Colitis
- 2'-Fucosyllactose
- Placebo
- (no location specified)
Sep 26, 2023
Ulcerative Colitis Trial in United States (Hyperbaric Oxygen Therapy, Sham Hyperbaric Air)
Not yet recruiting
- Ulcerative Colitis
- Hyperbaric Oxygen Therapy
- Sham Hyperbaric Air
-
Birmingham, Alabama
- +18 more
Aug 9, 2023
Mesenchymal Stem Cell, COVID-19 Pneumonia Trial in Shanghai (UC-MSCs treatment)
Recruiting
- Mesenchymal Stem Cell
- COVID-19 Pneumonia
- UC-MSCs treatment
-
Shanghai, Shanghai, ChinaShanghai East Hospital, Shanghai Tongji University
Jan 17, 2023
A Cohort Study Comparing IFX to CS for Moderate to Severe UC
Recruiting
- Moderate to Severe Ulcerative Colitis
-
Guandong, ChinaThe Sixth Affiliated Hospital, Sun Yat-sen University
Nov 22, 2022
Keloid, Stem Cell Trial in Jakarta Pusat (umbilical cord-derived mesenchymal stem cells (UC-MSC), umbilical cord-derived
Completed
- Keloid
- Stem Cell
- umbilical cord-derived mesenchymal stem cells (UC-MSC)
- +2 more
-
Jakarta Pusat, DKI Jakarta, IndonesiaRSPAD Gatot Soebroto
Jul 1, 2023
Keloid, Stem Cell Trial in Jakarta Pusat (umbilical cord-derived mesenchymal stem cells (UC-MSC), umbilical cord-derived
Completed
- Keloid
- Stem Cell
- umbilical cord-derived mesenchymal stem cells (UC-MSC)
- +2 more
-
Jakarta Pusat, DKI Jakarta, IndonesiaRSPAD Gatot Soebroto
Jun 5, 2023
Polycystic Ovary Syndrome Trial in Jakarta (WJ-MSCs, Secretomes, WJ-MSCs and Secretomes)
Recruiting
- Polycystic Ovary Syndrome
- UC-MSCs
- +3 more
-
Jakarta, IndonesiaPT Prodia StemCell Indonesia
Sep 23, 2022
Ulcerative Colitis, Irritable Bowel Syndrome Trial in Xinxiang (probiotics)
Recruiting
- Ulcerative Colitis
- Irritable Bowel Syndrome
- probiotics
-
Xinxiang, Henan, ChinaThe First Affiliated Hospital of Xinxiang Medical College
Dec 7, 2022
Ulcerative Colitis Flare, Ulcerative Colitis Trial in Nijmegen (Multimodal intervention program)
Not yet recruiting
- Ulcerative Colitis Flare
- Ulcerative Colitis
- Multimodal intervention program
-
Nijmegen, NetherlandsDorien Oomkens
Feb 14, 2023
A Prospective, Multi-center Study
Not yet recruiting
- Hematuria
- Urothelial Carcinoma
- urine sample collection
-
Shanghai, Shanghai, ChinaChanghai Hospital
May 29, 2023
Umbilical Cord Abnormalities in Prediction of Adverse Pregnancy
Not yet recruiting
- Small for Gestational Age at Delivery
- +3 more
- Umbilical cord measurements & observations
- (no location specified)
Jun 5, 2023